Schott launches InJentle syringe to improve drug stability

By Nick Taylor

- Last updated on GMT

Related tags: Pharmaceutical drug, Pharmacology

Schott AG has launched its InJentle syringe to improve the stability of highly sensitive drugs, which is a “major topic” for the company’s clients, according to a company director.

Speaking to in-PharmaTechnologist at Pharmapack 2010, Gregor Dudek, director, product management pharmaceutical packaging at Schott, explained that the syringe is designed to prevent the drug coming into contact with potential contaminants.

The syringe also has a tamper-evident closure and can be modified to include additional anti-counterfeiting features, such as radiofrequency identification (RFID) tags.

Additionally, sharper ‘virgin’ needles are used to make the injection less painful for patients. Particularly thin, siliconised needles can also be used to improve patient application.

Related topics: Drug Delivery, Delivery technologies

Related news

Show more

Related products

Spray Dried Powders for High Dose Drug Delivery

Spray Dried Powders for High Dose Drug Delivery

Catalent | 01-Feb-2022 | Product Presentation

This Catalent webinar will explore how spray dried particles provide an attractive, carrier-free option for highly dispersed delivery of API to deep lung...

Related suppliers

Follow us

Products

View more

Webinars